ARGOS THERAPEUTICS INC Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARGOS THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARGOS THERAPEUTICS INC for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,267 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,238 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Option Exercise | C | 0.00 | 75 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Buy | C | 0.00 | 1,267 | 0 | 2,580 | 1.3 K to 2.6 K (+96.50 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Buy | C | 0.00 | 1,238 | 0 | 1,313 | 75 to 1.3 K (+1,650.67 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Buy | C | 0.00 | 75 | 0 | 75 | 0 to 75 |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Option Exercise | C | 0.00 | 4,941 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Option Exercise | C | 0.00 | 619 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Option Exercise | C | 0.00 | 37 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Buy | C | 0.00 | 4,941 | 0 | 5,597 | 656 to 5.6 K (+753.20 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Buy | C | 0.00 | 619 | 0 | 656 | 37 to 656 (+1,672.97 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Buy | C | 0.00 | 37 | 0 | 37 | 0 to 37 |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Option Exercise | C | 0.00 | 1,859 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Option Exercise | C | 0.00 | 4,941 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Buy | C | 0.00 | 1,859 | 0 | 6,800 | 4.9 K to 6.8 K (+37.62 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Buy | C | 0.00 | 4,941 | 0 | 4,941 | 0 to 4.9 K |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Option Exercise | C | 0.00 | 569,990 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Option Exercise | C | 0.00 | 582,769 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Option Exercise | C | 0.00 | 43,185 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Option Exercise | C | 0.00 | 13,131 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | P | 8.00 | 40,497 | 323,976 | 1,249,572 | 1.2 M to 1.2 M (+3.35 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | C | 0.00 | 569,990 | 0 | 1,209,075 | 639.1 K to 1.2 M (+89.19 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | C | 0.00 | 582,769 | 0 | 639,085 | 56.3 K to 639.1 K (+1,034.82 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | C | 0.00 | 43,185 | 0 | 56,316 | 13.1 K to 56.3 K (+328.88 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | C | 0.00 | 13,131 | 0 | 13,131 | 0 to 13.1 K |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Option Exercise | C | 0.00 | 1,428,888 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Option Exercise | C | 0.00 | 984,840 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Buy | P | 8.00 | 36,416 | 291,328 | 2,450,144 | 2.4 M to 2.5 M (+1.51 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Buy | C | 0.00 | 1,428,888 | 0 | 2,413,728 | 984.8 K to 2.4 M (+145.09 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Buy | C | 0.00 | 984,840 | 0 | 984,840 | 0 to 984.8 K |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Option Exercise | C | 0.00 | 663,082 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Option Exercise | C | 0.00 | 665,583 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Option Exercise | C | 0.00 | 94,351 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Option Exercise | C | 0.00 | 8,202 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | P | 8.00 | 39,873 | 318,984 | 1,471,091 | 1.4 M to 1.5 M (+2.79 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | C | 0.00 | 663,082 | 0 | 1,431,218 | 768.1 K to 1.4 M (+86.32 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | C | 0.00 | 665,583 | 0 | 768,136 | 102.6 K to 768.1 K (+649.01 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | C | 0.00 | 94,351 | 0 | 102,553 | 8.2 K to 102.6 K (+1,150.34 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | C | 0.00 | 8,202 | 0 | 8,202 | 0 to 8.2 K |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | C | 0.00 | 1,428,888 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | C | 0.00 | 984,840 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | P | 8.00 | 36,416 | 291,328 | 2,450,144 | 2.4 M to 2.5 M (+1.51 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | C | 0.00 | 1,428,888 | 0 | 2,413,728 | 984.8 K to 2.4 M (+145.09 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | C | 0.00 | 984,840 | 0 | 984,840 | 0 to 984.8 K |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Pharmstandard International S. ... | 10% Owner | Option Exercise | C | 0.00 | 4,708,549 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Pharmstandard International S. ... | 10% Owner | Buy | P | 8.00 | 1,275,000 | 10,200,000 | 5,983,549 | 4.7 M to 6 M (+27.08 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Pharmstandard International S. ... | 10% Owner | Buy | C | 0.00 | 4,708,549 | 0 | 4,708,549 | 0 to 4.7 M |